PCM Encore’s ResMed RMD Stock Holding History

PCM Encore’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$327K	Sell	1,679 -19	-1%	-$3.94K	0.06%	305
2026 Q1	$381K	Sell	1,698 -14	-0.8%	-$3.49K	0.08%	261
2025 Q4	$412K	Buy	+1,712	New	+$438K	0.09%	227

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PCM Encore's RMD Position: Q2 2026 in Review

PCM Encore reduced its ResMed (RMD) stake by 1.1% in Q2 2026, selling an estimated $3.94K and leaving 1,679 shares worth $327K. The position accounts for 0.06% of the portfolio, ranked #305.

PCM Encore first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $412K in Q4 2025. 884 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

PCM Encore held 1,679 shares of ResMed worth $327K as of Q2 2026.
PCM Encore sold 19 ResMed shares in Q2 2026, an estimated $3.94K.
ResMed made up 0.06% of PCM Encore's portfolio in Q2 2026, its #305 holding.
PCM Encore first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
PCM Encore's ResMed position peaked at $412K in Q4 2025.
884 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.